In: Cellular and Molecular Life Sciences, 2015, vol. 72, no. 7, p. 1231-1248
|
In: The Journal of Infectious Diseases, 2018, vol. 217, no. 2, p. 270-279
|
In: Glycobiology, 2018, vol. 28, no. 9, p. 640-647
|
In: Glycobiology, 2016, vol. 26, no. 2, p. 111-128
|
In: Open forum infectious diseases, 2015, vol. 2, no. 3, p. ofv084
Background: Human noroviruses are the leading cause of acute viral gastroenteritis, justifying vaccine development despite a limited understanding of strain immunity. After genogroup I (GI).1 norovirus infection and immunization, blockade antibody titers to multiple virus-like particles (VLPs) increase, suggesting that GI cross-protection may occur. Methods: Immunoglobulin (Ig)A was purified...
|
In: Journal of Clinical Immunology, 2014, vol. 34, p. 51-55
|
In: Oecologia, 2014, vol. 174, no. 3, p. 631-638
|
In: Journal of Clinical Immunology, 2010, vol. 30, p. 24-30
|
In: Cellular and Molecular Life Sciences, 2011, vol. 68, no. 21, p. 3469-3478
|
In: Infection, 2006, vol. 34, no. 1, p. 35-38
|